Nicholas E Johnson1, Russell Butterfield2, Kiera Berggren2, Man Hung2, Wei Chen2, Deanna DiBella2, Melissa Dixon2, Heather Hayes2, Evan Pucillo2, Jerry Bounsanga2, Chad Heatwole2, Craig Campbell2. 1. From the Departments of Neurology (N.E.J., R.B., K.B., D.D., M.D., E.P.), Orthopaedics (M.H., J.B.), and Physical Therapy (H.H.), and Division of Epidemiology (M.H., W.C.), The University of Utah, Salt Lake City; Department of Neurology (C.H.), The University of Rochester, NY; and Departments of Pediatrics, Clinical Neurological Sciences, and Epidemiology (C.C.), Western University, London, Canada. Nicholas.johnson@hsc.utah.edu. 2. From the Departments of Neurology (N.E.J., R.B., K.B., D.D., M.D., E.P.), Orthopaedics (M.H., J.B.), and Physical Therapy (H.H.), and Division of Epidemiology (M.H., W.C.), The University of Utah, Salt Lake City; Department of Neurology (C.H.), The University of Rochester, NY; and Departments of Pediatrics, Clinical Neurological Sciences, and Epidemiology (C.C.), Western University, London, Canada.
Abstract
OBJECTIVE: Herein, we describe the disease burden and age-related changes of congenital-onset myotonic dystrophy (CDM) in childhood. METHODS: Children with CDM and age-matched controls aged 0 to 13 years were enrolled. Participants were divided into cohorts based on the following age groups: 0-2, 3-6, and 7-13 years. Each cohort received age-appropriate evaluations including functional testing, oral facial strength testing, neuropsychological testing, quality-of-life measurements, and ECG. Independent-samples t test or Wilcoxon 2-sample test was used to compare the differences between children with CDM and controls. Probability values less than 0.05 are reported as significant. RESULTS: Forty-one participants with CDM and 29 healthy controls were enrolled. The 6-minute walk was significantly different between CDM (258.3 m [SD 176.0]) and control participants (568.2 m [SD 73.2]). The mean lip force strength was significantly different in CDM (2.1 N [SD 2.8)] compared to control participants (17.8 N [SD 7.6]). In participants with CDM, the mean IQ (65.8; SD 18.4) was 3 SDs below the mean compared to standardized norms. Measurements of grip strength, sleep quality, and quality of life were also significantly different. Strength measures (oral facial strength, grip strength, and 6-minute walk) correlated with each other but not with participant IQ. CONCLUSIONS: This work identifies important phenotypes associated with CDM during childhood. Several measures of strength and function were significantly different between participants with CDM and controls and may be useful during future therapeutic trials.
OBJECTIVE: Herein, we describe the disease burden and age-related changes of congenital-onset myotonic dystrophy (CDM) in childhood. METHODS:Children with CDM and age-matched controls aged 0 to 13 years were enrolled. Participants were divided into cohorts based on the following age groups: 0-2, 3-6, and 7-13 years. Each cohort received age-appropriate evaluations including functional testing, oral facial strength testing, neuropsychological testing, quality-of-life measurements, and ECG. Independent-samples t test or Wilcoxon 2-sample test was used to compare the differences between children with CDM and controls. Probability values less than 0.05 are reported as significant. RESULTS: Forty-one participants with CDM and 29 healthy controls were enrolled. The 6-minute walk was significantly different between CDM (258.3 m [SD 176.0]) and control participants (568.2 m [SD 73.2]). The mean lip force strength was significantly different in CDM (2.1 N [SD 2.8)] compared to control participants (17.8 N [SD 7.6]). In participants with CDM, the mean IQ (65.8; SD 18.4) was 3 SDs below the mean compared to standardized norms. Measurements of grip strength, sleep quality, and quality of life were also significantly different. Strength measures (oral facial strength, grip strength, and 6-minute walk) correlated with each other but not with participant IQ. CONCLUSIONS: This work identifies important phenotypes associated with CDM during childhood. Several measures of strength and function were significantly different between participants with CDM and controls and may be useful during future therapeutic trials.
Authors: Nicholas E Johnson; Anne-Berit Ekstrom; Craig Campbell; Man Hung; Heather R Adams; Wei Chen; Elizabeth Luebbe; James Hilbert; Richard T Moxley; Chad R Heatwole Journal: Dev Med Child Neurol Date: 2015-10-28 Impact factor: 5.449
Authors: M Mahadevan; C Tsilfidis; L Sabourin; G Shutler; C Amemiya; G Jansen; C Neville; M Narang; J Barceló; K O'Hoy Journal: Science Date: 1992-03-06 Impact factor: 47.728
Authors: Y H Fu; A Pizzuti; R G Fenwick; J King; S Rajnarayan; P W Dunne; J Dubel; G A Nasser; T Ashizawa; P de Jong Journal: Science Date: 1992-03-06 Impact factor: 47.728
Authors: J D Brook; M E McCurrach; H G Harley; A J Buckler; D Church; H Aburatani; K Hunter; V P Stanton; J P Thirion; T Hudson Journal: Cell Date: 1992-02-21 Impact factor: 41.582
Authors: Silvia Ulrich; Florian F Hildenbrand; Ursula Treder; Manuel Fischler; Stephan Keusch; Rudolf Speich; Margrit Fasnacht Journal: BMC Pulm Med Date: 2013-08-05 Impact factor: 3.317
Authors: Craig M McDonald; Erik K Henricson; R Ted Abresch; Julaine M Florence; Michelle Eagle; Eduard Gappmaier; Allan M Glanzman; Robert Spiegel; Jay Barth; Gary Elfring; Allen Reha; Stuart Peltz Journal: Muscle Nerve Date: 2013-06-26 Impact factor: 3.217
Authors: Evan M Pucillo; Deanna L Dibella; Man Hung; Jerry Bounsanga; Becky Crockett; Melissa Dixon; Russell J Butterfield; Craig Campbell; Nicholas E Johnson Journal: Muscle Nerve Date: 2017-02-13 Impact factor: 3.217
Authors: Siham Ait Benichou; Dominic Jauvin; Thiéry De Serres-Bérard; Marion Pierre; Karen K Ling; C Frank Bennett; Frank Rigo; Genevieve Gourdon; Mohamed Chahine; Jack Puymirat Journal: Gene Ther Date: 2022-01-25 Impact factor: 5.250
Authors: Kiera N Berggren; Man Hung; Melissa M Dixon; Jerry Bounsanga; Becky Crockett; Mary D Foye; Yushan Gu; Craig Campbell; Russell J Butterfield; Nicholas E Johnson Journal: Muscle Nerve Date: 2018-09 Impact factor: 3.217
Authors: James D Thomas; Łukasz J Sznajder; Olgert Bardhi; Faaiq N Aslam; Zacharias P Anastasiadis; Marina M Scotti; Ichizo Nishino; Masayuki Nakamori; Eric T Wang; Maurice S Swanson Journal: Genes Dev Date: 2017-07-11 Impact factor: 11.361
Authors: Ashish N Rao; Hannah M Campbell; Xiangnan Guan; Tarah A Word; Xander Ht Wehrens; Zheng Xia; Thomas A Cooper Journal: JCI Insight Date: 2021-03-08
Authors: Silvie Franck; Edouard Couvreu De Deckersberg; Jodi L Bubenik; Christina Markouli; Lise Barbé; Joke Allemeersch; Pierre Hilven; Geoffrey Duqué; Maurice S Swanson; Alexander Gheldof; Claudia Spits; Karen D Sermon Journal: Biol Open Date: 2022-01-12 Impact factor: 2.643